Novel compounds and compositions for treating diseases associated with tryptase activity
LT99019A
Novel compounds and compositions for treating diseases associated with tryptase activity
WO9909413A1
Anti-tryptase detection as a diagnostic for inflammatory diseases
AU3492497A
Bivalent molecules that form an activating complex with an erythropoietin receptor
US6485964B1
Transgenic mammals lacking expression of erythropoietin or of erythropoietin receptor, transgenic mammals expressing chimeric erythropoietin receptors, constructs for producing the transgenic mammals and uses therefor
AU7476296A
Novel subtilisin inhibitors
TW438591B
Reversible cysteine protease inhibitors
US5776718A
Reversible protease inhibitors
SI9520101A
Compositions and methods for treating mast-cell inflammatory condition
WO9532945A1
Compositions and methods for treating mast-cell mediated conditions
US5693515A
Metal complexed serine protease inhibitors
AU2091095A
Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups
US5703792A
Three dimensional measurement of molecular diversity
WO9420527A1
Compositions and methods for the treatment of immunomediated inflammatory disorders
US5525623A
Compositions and methods for the treatment of immunomediated inflammatory disorders
WO9419694A1
Thin film hpmp matrix systems and methods for constructing and displaying ligands
US5585275A
Pilot apparatus for peptide synthesis and screening
US5576220A
Thin film HPMP matrix systems and methods for constructing and displaying ligands
